Ampio Pharmaceuticals Profile

0.55
USD 0.08  16.13%
3%
33%

Acquisition by David BarOr of 300000 shares of Ampio Pharmaceuticals subject to Rule 16b-3

Ampio Pharmaceuticals insider trading alert for grant of stock option (right to buy) by David BarOr, Chief Scientific Officer, on August 13, 2018. This event was filed by Ampio Pharmaceuticals Inc with SEC on 2014-08-15. Statement of changes in beneficial ownership - SEC Form 4. David BarOr is currently serves as chief scientific officer, director of Ampio Pharmaceuticals [view details]   

Ampio Pharmaceuticals Summary

Ampio Pharmaceuticals (AMPE) is traded on BATS Exchange in USA. It is located in COLORADO U.S.A and employs 17 people. Ampio Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 47.61 M. Ampio Pharmaceuticals conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 86.32 M outstanding shares of which 14.98 M shares are presently shorted by private and institutional investors with about 14.79 trading days to cover. AMPIO PHARMACEUTI currently holds about 7.52 M in cash with (12.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Ampio Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 0.5516HorizonTargetOdds Above 0.5516
1.06%30 days 0.55 98.93%
Based on normal probability distribution, the odds of Ampio Pharmaceuticals to move above current price in 30 days from now is about 99.0% (This Ampio Pharmaceuticals probability density function shows the probability of Ampio Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares5.2 M11.3 M
Cypress Capital Management Llc WyCommon Shares321.7 K708 K
Trustcore Financial Services LlcCall Options44.5 K98 K
View Ampio Pharmaceuticals Diagnostics

Selected Ampio Pharmaceuticals Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Ampio Pharmaceuticals Against Markets

Current Ratings

Ampio Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
68 
Equity ratings for Ampio Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. Ampio Pharmaceuticals operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 17 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Ampio Pharmaceuticals SEC Filings
Ampio Pharmaceuticals SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAmpio Pharmaceuticals
ChairmanPhilip CoelhoView All
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationCOLORADO U.S.A
Business Address373 Inverness Parkway
ExchangeBATS Exchange
CIK Number0001411906
CUSIP03209T109
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.ampiopharma.com
Phone720 437 6500
CurrencyUSD - US Dollar

Executives

Ampio Pharmaceuticals Corporate Executives
Thomas Chilcott Interim CFO
Gregory Gould CFO, Treasurer, Corporate Secretary
Holli Cherevka COO
Check also Trending Equities. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.